Desveneurax 50 mg
Desveneurax 50 mg is a medicine authorised by Swissmedic under authorisation number 69469. The authorisation holder is Neuraxpharm Switzerland AG. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 22 November 2024 and the authorisation is limited until 21 November 2029. ATC code N06AX23 places the medicine in the group Psychoanaleptics.
| Authorisation number | 69469 |
|---|---|
| Name | Desveneurax 50 mg |
| Full name | Desveneurax 50 mg, Retardtabletten |
| Authorisation holder | Neuraxpharm Switzerland AG |
| Medicinal product code | Synthetic medicines |
| Dispensing category | B · Prescription only |
| ATC code | N06AX23 |
| First authorisation | 22 November 2024 |
| Authorisation validity | 21 November 2029 |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Desveneurax 50 mg, Retardtabletten | B | 22 November 2024 |
| 2 | Desveneurax 100 mg, Retardtabletten | B | 22 November 2024 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 20 | Tablette(n) | N06AX23 | 01.06.0. | B |
| 2 | 28 | Tablette(n) | N06AX23 | 01.06.0. | B |
| 3 | 50 | Tablette(n) | N06AX23 | 01.06.0. | B |
| 4 | 100 | Tablette(n) | N06AX23 | 01.06.0. | B |
| 5 | 28 | Tablette(n) | N06AX23 | 01.06.0. | B |
| 6 | 50 | Tablette(n) | N06AX23 | 01.06.0. | B |
| 7 | 100 | Tablette(n) | N06AX23 | 01.06.0. | B |
Scroll the table sideways
Other medicines from this authorisation holder
Frequently asked questions
Is Desveneurax 50 mg authorised in Switzerland?
Yes. Desveneurax 50 mg is authorised by Swissmedic under authorisation number 69469, data as of 01 September 2026. The authorisation is limited until 21 November 2029.
Which dispensing category does Desveneurax 50 mg have?
Desveneurax 50 mg is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Desveneurax 50 mg?
The authorisation holder is Neuraxpharm Switzerland AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.